Wednesday, November 6, 2019, 9:30 am to 10:30 am
101 NEC Auditorium
Speaker: Mark R. Kelley, Ph.D.
Associate Director of Basic Science Research
Indiana University Simon Cancer Center
Topic: Exploiting the Ref-1/APE1 signaling node for targeted cancer therapy and other indications: From bench to first-in-class clinical trial
Host: Dr. Ravi Sahu
Log in to submit a correction for this event (subject to moderation).